Liminal BioSciences
Bruce was appointed as Chief Executive Officer, effective 13 November 2020. Prior to that he was one of 2 Chief Operating Officers In this role he was responsible for the company’s discovery, clinical development, program management, CMC and business development functions related to Small Molecule Therapeutics.
This person is not in any offices
Liminal BioSciences
Liminal is a biopharmaceutical corporation supplying state-of-the-art technologies for bio-separations as well as therapeutic products.